CV Sciences (CVSI) Revenue (2013 - 2026)
CV Sciences (CVSI) posted Revenue of $3.2 million for Q1 2026, down 3.39% sequentially from $3.3 million in Q4 2025, and down 11.4% YoY from $3.6 million in Q1 2025.
CV Sciences (CVSI) Revenue (2013 - 2026) Analysis & Trends
CV Sciences has reported Revenue for 14 years, with the latest figure at $3.2 million in Q1 2026.
- Quarterly Revenue fell 11.4% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.4 million (down 12.61% YoY) and the FY2025 annual result came in at $13.8 million, down 12.2% from the prior year.
- Revenue retreated to $3.2 million in Q1 2026 per CVSI's latest filing, from $3.3 million in the prior quarter.
- Over five years, Revenue peaked at $4.4 million in Q1 2022 and troughed at $3.2 million in Q1 2026.
- A 5-year average of $3.8 million and a median of $3.9 million in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue slipped 26.55% in 2022, then grew 9.01% in 2023.
- Over 5 years, Revenue stood at $3.9 million in 2022, then slipped by 1.76% to $3.8 million in 2023, then climbed by 2.18% to $3.9 million in 2024, then slipped by 14.86% to $3.3 million in 2025, then retreated by 3.39% to $3.2 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $3.2 million, $3.3 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 Mn |
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 3.31 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.62 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | 3.87 Mn |
| Jun 30, 2024 | 3.95 Mn |
| Mar 31, 2024 | 4.00 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 4.09 Mn |
| Jun 30, 2023 | 3.97 Mn |
| Mar 31, 2023 | 4.15 Mn |
| Dec 31, 2022 | 3.87 Mn |
| Sep 30, 2022 | 3.75 Mn |
| Jun 30, 2022 | 4.14 Mn |
| Mar 31, 2022 | 4.45 Mn |
| Dec 31, 2021 | 4.97 Mn |
| Sep 30, 2021 | 5.11 Mn |